Pfizer Confident That Caduet Will Succeed; How Safe Is Sales Force?
Executive Summary
Pfizer hopes that a rewording of the indications section for Caduet will help the combination product live up to the company's expectations
You may also be interested in...
Pfizer Plans Exubera “Full Court Press”’ In 2007 After 2006 Stumbles
Pfizer is finally ramping up for a full-scale launch of the inhaled insulin Exubera - targeting primary care physicians and consumers - over one year after the drug was approved by FDA
Pfizer Plans Exubera “Full Court Press”’ In 2007 After 2006 Stumbles
Pfizer is finally ramping up for a full-scale launch of the inhaled insulin Exubera - targeting primary care physicians and consumers - over one year after the drug was approved by FDA
AstraZeneca Cuts Sales Reps By Reducing PDI Contract; Will Others Follow?
AstraZeneca's decision to reduce the number of contract sales reps may be an early indicator of an industry trend in 2005